ANI PHARMACEUTICALS INC
ANIP · NASDAQ
Updated at 2026-10-13 11:05:27
- Today's High
- --
- Today’s Low
- --
%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23150%3B%26%23135%3B%26%23230%3B%26%23161%3B%26%23163%3B%26%23230%3B%26%23154%3B%26%23151%3B%26%23232%3B%26%23167%3B%26%23146%3B%22%20d%3D%22M48.3363%2013.4132H60.2082L46.795%205.72205e-06V11.8719C46.795%2012.7231%2047.4851%2013.4132%2048.3363%2013.4132Z%22%20fill%3D%22var(--fill-0%2C%20%23474741)%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23148%3B%26%23190%3B%26%23229%3B%26%23164%3B%26%23167%3B%26%23233%3B%26%23149%3B%26%23156%3B%22%20fill-rule%3D%22evenodd%22%20clip-rule%3D%22evenodd%22%20d%3D%22M11.3812%2020.3725C16.7977%2014.9559%2025.5803%2014.9559%2030.9969%2020.3725C36.413%2025.789%2036.4131%2034.5707%2030.9969%2039.9872C26.0109%2044.973%2018.1729%2045.3699%2012.7335%2041.1769L2.54298%2051.3684L0%2048.8254L10.1915%2038.6329C5.99993%2033.1937%206.39609%2025.3579%2011.3812%2020.3725ZM28.4539%2022.9155C24.4418%2018.9033%2017.9363%2018.9033%2013.9241%2022.9155C9.91245%2026.9275%209.91241%2033.4322%2013.9241%2037.4442C17.9362%2041.4562%2024.4418%2041.4562%2028.4539%2037.4442C32.4656%2033.4322%2032.4656%2026.9275%2028.4539%2022.9155Z%22%20fill%3D%22var(--fill-0%2C%20%235D5D56)%22%2F%3E%0A%3C%2Fg%3E%0A%20%20%3C%2Fsvg%3E%0A%3C%2Fsvg%3E%0A)
Candlestick trends are for reference. Refer to the trading page for actual data.
Key Statistics
- Previous Open
- $74.00
- Previous Close
- $73.59
- Volume
- 318.47K
- Market Cap
- $1.69B
- P/E Ratio
- 15.59X
- EPS
- $4.99
Previous Day Range
52-Week Range
Company Overview
- Sector
- HEALTHCARE
- Industry
- Pharmaceuticals
- Sub-industry
- DRUG MANUFACTURERS - SPECIALTY & GENERIC
- Headquarters
- 210 MAIN STREET WEST, BAUDETTE, MN, UNITED STATES, 56623
- Country
- US
- Listing Date
- 2000-05-04
- Fiscal Year End
- December
- Shares Outstanding
- 22.75M
- CIK
- 0001023024
- Website
- www.anipharmaceuticals.com
ANI Pharmaceuticals, Inc., a specialty pharmaceutical company, develops, manufactures, and markets brand-name and generic prescription pharmaceuticals in the United States and Canada. The company is headquartered in Baudette, Minnesota.
Financial Metrics
Revenue
2026-06-30
$266.04M
2026-03-31
$237.46M
2025-12-31
$247.06M
2025-09-30
$227.81M
Operating Expenses
2026-06-30
$125.42M
2026-03-31
$84.25M
2025-12-31
$189.38M
2025-09-30
$88.96M
Net Income
2026-06-30
$24.71M
2026-03-31
$29.49M
2025-12-31
$27.49M
2025-09-30
$24.13M
Net Profit Margin
2026-06-30
9.28%
2026-03-31
12.41%
2025-12-31
11.12%
2025-09-30
10.59%
Earnings Per Share
2026-06-30
$1.82
2026-03-31
$1.68
2025-12-31
$2.33
2025-09-30
$2.04
Earnings Before Interest, Taxes, Depreciation, and Amortization
2026-06-30
$60.37M
2026-03-31
$57.37M
2025-12-31
$76.93M
2025-09-30
$61.15M
Effective Tax Rate
2026-06-30
33.38%
2026-03-31
26.67%
2025-12-31
12.67%
2025-09-30
21.25%
| Item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
| Revenue | $266.04M | $237.46M | $247.06M | $227.81M |
| Operating Expenses | $125.42M | $84.25M | $189.38M | $88.96M |
| Net Income | $24.71M | $29.49M | $27.49M | $24.13M |
| Net Profit Margin | 9.28% | 12.41% | 11.12% | 10.59% |
| Earnings Per Share | $1.82 | $1.68 | $2.33 | $2.04 |
| Earnings Before Interest, Taxes, Depreciation, and Amortization | $60.37M | $57.37M | $76.93M | $61.15M |
| Effective Tax Rate | 33.38% | 26.67% | 12.67% | 21.25% |
FAQs
Risk Warning
Stock prices can be highly volatile and may rise or fall sharply in a short period. Digital asset and derivative products involve additional risks such as leverage and liquidity. Content on this page is for reference only and does not constitute investment advice. Product availability and access may vary by region and applicable regulations.